Clorox Co (NYSE:CLX) Shares Bought by Whittier Trust Co.

Whittier Trust Co. boosted its stake in shares of Clorox Co (NYSE:CLX) by 1.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,962 shares of the company’s stock after buying an additional 88 shares during the quarter. Whittier Trust Co.’s holdings in Clorox were worth $913,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of CLX. Zions Bancorporation N.A. purchased a new position in Clorox during the first quarter worth approximately $28,000. Northstar Capital Management LLC purchased a new position in shares of Clorox in the 1st quarter valued at $29,000. Paragon Capital Management LLC purchased a new position in shares of Clorox in the 1st quarter valued at $35,000. Penserra Capital Management LLC purchased a new position in shares of Clorox in the 1st quarter valued at $36,000. Finally, Trustcore Financial Services LLC purchased a new position in shares of Clorox in the 1st quarter valued at $38,000. Institutional investors own 76.83% of the company’s stock.

A number of brokerages have recently commented on CLX. Bank of America reissued a “neutral” rating and issued a $154.00 target price (down previously from $165.00) on shares of Clorox in a research note on Thursday, May 2nd. Morgan Stanley raised their target price on shares of Clorox from $141.00 to $144.00 and gave the company an “underweight” rating in a research note on Friday. Deutsche Bank raised shares of Clorox from a “sell” rating to a “hold” rating and set a $139.00 target price on the stock in a research note on Thursday, May 2nd. JPMorgan Chase & Co. downgraded shares of Clorox from a “neutral” rating to an “underweight” rating and cut their target price for the company from $159.00 to $139.00 in a research note on Monday, April 8th. Finally, Royal Bank of Canada raised their target price on shares of Clorox to $161.00 and gave the company a “sector perform” rating in a research note on Friday. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the company. Clorox has a consensus rating of “Hold” and an average price target of $154.07.

CLX traded down $1.72 during trading hours on Monday, reaching $155.18. 20,305 shares of the stock traded hands, compared to its average volume of 971,180. The business’s fifty day moving average price is $157.77. The firm has a market cap of $19.98 billion, a P/E ratio of 24.64, a price-to-earnings-growth ratio of 4.59 and a beta of 0.36. Clorox Co has a fifty-two week low of $139.26 and a fifty-two week high of $167.70. The company has a current ratio of 0.91, a quick ratio of 0.66 and a debt-to-equity ratio of 4.09.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.84 by $0.04. The business had revenue of $1.63 billion during the quarter, compared to analyst estimates of $1.69 billion. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The business’s revenue was down 3.8% on a year-over-year basis. During the same period last year, the business earned $1.66 EPS. Analysts predict that Clorox Co will post 6.4 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Wednesday, July 31st will be issued a dividend of $1.06 per share. This represents a $4.24 dividend on an annualized basis and a yield of 2.73%. This is a positive change from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date of this dividend is Tuesday, July 30th. Clorox’s dividend payout ratio (DPR) is presently 67.09%.

In other Clorox news, SVP Denise Garner sold 20,399 shares of the firm’s stock in a transaction on Friday, June 7th. The shares were sold at an average price of $157.61, for a total transaction of $3,215,086.39. Following the completion of the transaction, the senior vice president now directly owns 4,896 shares of the company’s stock, valued at approximately $771,658.56. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.40% of the stock is currently owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: Why do commodities matter?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.